- Home
- IDN vs MAIA Comparison
IDN vs MAIA Comparison
Compare IDN & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- MAIA
- Stock Information
- Founded
- IDN 1994
- MAIA 2018
- Country
- IDN United States
- MAIA United States
- Employees
- IDN N/A
- MAIA N/A
- Industry
- IDN Computer Software: Prepackaged Software
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- IDN Technology
- MAIA Health Care
- Exchange
- IDN Nasdaq
- MAIA Nasdaq
- Market Cap
- IDN 50.8M
- MAIA 52.8M
- IPO Year
- IDN 1999
- MAIA 2022
- Fundamental
- Price
- IDN $2.65
- MAIA $1.85
- Analyst Decision
- IDN Buy
- MAIA
- Analyst Count
- IDN 3
- MAIA 0
- Target Price
- IDN $3.33
- MAIA N/A
- AVG Volume (30 Days)
- IDN 59.1K
- MAIA 356.4K
- Earning Date
- IDN 03-20-2025
- MAIA 03-20-2025
- Dividend Yield
- IDN N/A
- MAIA N/A
- EPS Growth
- IDN N/A
- MAIA N/A
- EPS
- IDN N/A
- MAIA N/A
- Revenue
- IDN $19,236,000.00
- MAIA N/A
- Revenue This Year
- IDN $2.09
- MAIA N/A
- Revenue Next Year
- IDN $8.67
- MAIA N/A
- P/E Ratio
- IDN N/A
- MAIA N/A
- Revenue Growth
- IDN 5.22
- MAIA N/A
- 52 Week Low
- IDN $1.67
- MAIA $1.24
- 52 Week High
- IDN $4.46
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- IDN 48.32
- MAIA 44.20
- Support Level
- IDN $2.51
- MAIA $1.83
- Resistance Level
- IDN $2.70
- MAIA $1.94
- Average True Range (ATR)
- IDN 0.16
- MAIA 0.15
- MACD
- IDN -0.01
- MAIA 0.01
- Stochastic Oscillator
- IDN 36.84
- MAIA 15.09
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.